A waiting area at Oregon Health & Science University’s (OHSU) Knight Cancer Treatment Center in Portland, Oregon, provides a welcoming space for patients and families receiving cancer care. The facility is designed to support comfort and patient-centered care. (OHSU/Christine Torres Hicks)

Steven Mansoor, M.D., Ph.D., and his research team at Oregon Health & Science University made a groundbreaking discovery by determining the first complete structure of a protein linked to various health issues, from cancer to nerve pain to brain disorders. (OHSU/Christine Torres Hicks)

Luiz Bertassoni, D.D.S., Ph.D., founding director of the Knight Cancer Precision Biofabrication Hub and professor in the OHSU Division of Oncological Sciences, has helped develop a method to engineer artificial blood vessels that can support tooth regeneration. The approach could transform future root canal treatments by restoring living tissue instead of removing it. (OHSU)

Luiz Bertassoni, D.D.S., Ph.D., founding director of the Knight Cancer Precision Biofabrication Hub and professor in the OHSU Division of Oncological Sciences, has helped develop a method to engineer artificial blood vessels that can support tooth regeneration. The approach could transform future root canal treatments by restoring living tissue instead of removing it. (OHSU)

Luiz Bertassoni, D.D.S., Ph.D., founding director of the Knight Cancer Precision Biofabrication Hub and professor in the OHSU Division of Oncological Sciences, has helped develop a method to engineer artificial blood vessels that can support tooth regeneration. The approach could transform future root canal treatments by restoring living tissue instead of removing it. (OHSU)

Eric Roeland, M.D., centro, se unió al OHSU Knight Cancer Institute con la misión de desarrollar un programa de investigación centrado en minimizar la toxicidad relacionada con el tratamiento y mejorar la calidad de vida de las personas que viven con cáncer. Roeland es profesor asociado de medicina en la Facultad de Medicina de OHSU. Tanja Glujic-White, izquierda, y Paula Cisternas Labadzinzki, miembros del equipo de investigación clínica en oncología. (OHSU/Christine Torres Hicks)